Los Angeles Capital Management
VIR icon

Los Angeles Capital Management’s Vir Biotechnology VIR Stock Holding History

Los Angeles Capital Management’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$184K Sell
20,480
-2,100
-9% -$16.7K ﹤0.01% 1168
2025
Q4 		$134K Sell
22,580
-18,630
-45% -$111K ﹤0.01% 1348
2025
Q3 		$235K Buy
41,210
+28,640
+228% +$146K ﹤0.01% 1218
2025
Q2 		$63.4K Buy
+12,570
New +$67.4K ﹤0.01% 1287
2025
Q1 		– Sell
-13,560
Closed -$99.5K – 1236
2024
Q4 		$99.5K Sell
13,560
-20
-0.1% -$158 ﹤0.01% 1086
2024
Q3 		$102K Buy
13,580
+249
+2% +$2.16K ﹤0.01% 1142
2024
Q2 		$119K Buy
+13,331
New +$128K ﹤0.01% 1151
2023
Q2 		– Sell
-23,257
Closed -$541K – 1300
2023
Q1 		$541K Sell
23,257
-39,668
-63% -$1.01M ﹤0.01% 835
2022
Q4 		$1.59M Sell
62,925
-949
-1% -$23.3K 0.01% 577
2022
Q3 		$1.23M Buy
63,874
+48,414
+313% +$1.23M 0.01% 628
2022
Q2 		$394K Sell
15,460
-24,689
-61% -$576K ﹤0.01% 1056
2022
Q1 		$1.03M Buy
40,149
+22,397
+126% +$664K ﹤0.01% 744
2021
Q4 		$743K Buy
17,752
+6,581
+59% +$258K ﹤0.01% 834
2021
Q3 		$486K Buy
11,171
+10
+0.1% +$433 ﹤0.01% 1052
2021
Q2 		$528K Sell
11,161
-600
-5% -$27.3K ﹤0.01% 1144
2021
Q1 		$603K Sell
11,761
-13,353
-53% -$720K ﹤0.01% 1128
2020
Q4 		$673K Buy
25,114
+12,036
+92% +$391K ﹤0.01% 1090
2020
Q3 		$449K Buy
+13,078
New +$563K ﹤0.01% 1124

Other funds holding VIR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
GP
GSK plc London $599M AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Los Angeles Capital Management's VIR Position: Q1 2026 in Review

Los Angeles Capital Management reduced its Vir Biotechnology (VIR) stake by 9.3% in Q1 2026, selling an estimated $16.7K and leaving 20,480 shares worth $184K. The position accounts for ﹤0.01% of the portfolio, ranked #1168.

Los Angeles Capital Management first reported a position in VIR in Q3 2020 and has held it in 18 quarters since. The position peaked at $1.59M in Q4 2022. 251 funds tracked by Wall St. Rank hold VIR as of Q1 2026.

  • Los Angeles Capital Management held 20,480 shares of Vir Biotechnology worth $184K as of Q1 2026.
  • Los Angeles Capital Management sold 2,100 Vir Biotechnology shares in Q1 2026, an estimated $16.7K.
  • Vir Biotechnology made up ﹤0.01% of Los Angeles Capital Management's portfolio in Q1 2026, its #1168 holding.
  • Los Angeles Capital Management first reported a position in Vir Biotechnology in Q3 2020 and has held it in 18 quarters since.
  • Los Angeles Capital Management's Vir Biotechnology position peaked at $1.59M in Q4 2022.
  • 251 funds tracked by Wall St. Rank held Vir Biotechnology as of Q1 2026.

Based on Los Angeles Capital Management's 13F filing for Q1 2026, filed 8 May 2026.